ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 115 filers reported holding ANAPTYSBIO INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $167,926 | -9.8% | 9,350 | +2.2% | 0.00% | 0.0% |
| Q2 2023 | $186,152 | -12.5% | 9,152 | -6.4% | 0.00% | 0.0% |
| Q1 2023 | $212,813 | -28.4% | 9,780 | +2.0% | 0.00% | -50.0% |
| Q4 2022 | $297,039 | +21.2% | 9,585 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $245,000 | +26.9% | 9,620 | +1.4% | 0.00% | +100.0% |
| Q2 2022 | $193,000 | -18.6% | 9,485 | -0.9% | 0.00% | 0.0% |
| Q1 2022 | $237,000 | -33.4% | 9,573 | -6.6% | 0.00% | -50.0% |
| Q4 2021 | $356,000 | +24.5% | 10,246 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $286,000 | +2.1% | 10,553 | -2.3% | 0.00% | +100.0% |
| Q2 2021 | $280,000 | +4.1% | 10,804 | -13.4% | 0.00% | 0.0% |
| Q1 2021 | $269,000 | +0.4% | 12,479 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $268,000 | +41.8% | 12,445 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $189,000 | -35.5% | 12,803 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $293,000 | +42.9% | 13,094 | -10.0% | 0.00% | 0.0% |
| Q1 2020 | $205,000 | -18.0% | 14,543 | -5.5% | 0.00% | 0.0% |
| Q4 2019 | $250,000 | -54.0% | 15,383 | -0.8% | 0.00% | -50.0% |
| Q3 2019 | $543,000 | -38.4% | 15,512 | -0.7% | 0.00% | -33.3% |
| Q2 2019 | $881,000 | -10.5% | 15,621 | +16.0% | 0.00% | -25.0% |
| Q1 2019 | $984,000 | +10.9% | 13,469 | -3.1% | 0.00% | 0.0% |
| Q4 2018 | $887,000 | -29.4% | 13,906 | +10.4% | 0.00% | 0.0% |
| Q3 2018 | $1,256,000 | +46.2% | 12,591 | +4.2% | 0.00% | +33.3% |
| Q2 2018 | $859,000 | -27.7% | 12,086 | +5.9% | 0.00% | -25.0% |
| Q1 2018 | $1,188,000 | -1.9% | 11,411 | -5.1% | 0.00% | 0.0% |
| Q4 2017 | $1,211,000 | +334.1% | 12,025 | +50.8% | 0.00% | +300.0% |
| Q3 2017 | $279,000 | +253.2% | 7,972 | +140.5% | 0.00% | – |
| Q2 2017 | $79,000 | – | 3,315 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |